Caption Management’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Caption Management's TEVA Position: Q3 2026 in Review
Caption Management increased its Teva Pharmaceutical Industries (TEVA) stake by 20% in Q3 2026, buying an estimated $1.85M and bringing the position to 310,000 shares worth $12.3M. The position accounts for 0.05% of the portfolio, ranked #385.
Caption Management first reported a position in TEVA in Q4 2018 and has held it in 17 quarters since. 600 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.
- Caption Management held 310,000 shares of Teva Pharmaceutical Industries worth $12.3M as of Q3 2026.
- Caption Management bought 51,669 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $1.85M.
- Teva Pharmaceutical Industries made up 0.05% of Caption Management's portfolio in Q3 2026, its #385 holding.
- Caption Management first reported a position in Teva Pharmaceutical Industries in Q4 2018 and has held it in 17 quarters since.
- 600 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.
Based on Caption Management's 13F filing for Q3 2026, filed 16 Nov 2026.